Growth hormone for short children without a hormone deficiency: Issues and practices.

التفاصيل البيبلوغرافية
العنوان: Growth hormone for short children without a hormone deficiency: Issues and practices. (cover story)
المؤلفون: Lee, Joyce M., Menon, Ram K.
المصدر: Contemporary Pediatrics; Oct2005, Vol. 22 Issue 10, p46-53, 6p, 2 Color Photographs, 3 Charts
مصطلحات موضوعية: SOMATOTROPIN, CLINICAL indications, PITUITARY dwarfism, CHRONIC kidney failure in children, TURNER'S syndrome, PRADER-Willi syndrome, SHORT stature
الشركة/الكيان: UNITED States. Food & Drug Administration
مستخلص: This article discusses the indications for growth hormone (GH) in children who are not GH-deficient which have gained approval from the U.S. Food and Drug Administration (FDA) as of 2005. Children with chronic renal insufficiency, Turner syndrome, or Prader-Willi syndrome, children who are born small for gestational age and children with idiopathic short stature are all eligible for recombinant GH therapy. The article reviews practical aspects of GH therapy, then discuss each of the FDA-approved GH indications. INSET: When parents ask about GH for a child in the normal height range.
قاعدة البيانات: Complementary Index